ID   AG07438
AC   CVCL_X870
SY   AG7438; AG07438A
DR   CLO; CLO_0035824
DR   Coriell; AG07438
DR   Wikidata; Q54740695
RX   CelloPub=CLPUB00597;
RX   PubMed=17668376;
RX   PubMed=24119401;
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
RX   CelloPub=CLPUB00597;
RG   National Institute on Aging;
RT   "1994 catalog of cell lines. NIA Aging Cell Repository.";
RL   (In misc. document) Institute for Medical Research (Camden, N.J.); pp.1-351; National Institutes of Health; Bethesda; USA (1994).
//
RX   PubMed=17668376; DOI=10.1086/519248; PMCID=PMC1950802;
RA   Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge-Vivier C.,
RA   Delorenzi M., Gehrig C., Descombes P., Sherman S.L.,
RA   Dagna-Bricarelli F., Baldo C., Novelli A., Dallapiccola B.,
RA   Antonarakis S.E.;
RT   "Natural gene-expression variation in Down syndrome modulates the
RT   outcome of gene-dosage imbalance.";
RL   Am. J. Hum. Genet. 81:252-263(2007).
//
RX   PubMed=24119401; DOI=10.1016/j.molcel.2013.09.009; PMCID=PMC4039290;
RA   Chen J.-Y., Lin J.-R., Tsai F.-C., Meyer T.;
RT   "Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to
RT   control the decision to enter the cell cycle.";
RL   Mol. Cell 52:87-100(2013).
//